{"id":"W4318904237","doi":"10.1200/jco.2023.41.4_suppl.183","title":"Plasma phosphocreatine (PC) as a predictive biomarker for immune checkpoint inhibition in patients with refractory metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Bausch Health (Canada); Hôpital du Sacré-Cœur de Montréal; Juravinski Cancer Centre; Cancer Care Nova Scotia; Jewish General Hospital; Hôpital Charles-Le Moyne; St. John’s Health Sciences Centre; BC Cancer Agency; Hôtel-Dieu de Québec; Saskatchewan Cancer Agency; University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; Queen's University; Moncton Hospital","funders":"","keywords":"Medicine; Hazard ratio; Colorectal cancer; Internal medicine; Oncology; Biomarker; Refractory (planetary science); Proportional hazards model; Gastroenterology; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003534603,0.0009826219,0.002643738,0.0003979641,0.0002901589,0.0009654481,0.0006071829,0.001097051,0.001430492],"category_scores_gemma":[0.003016987,0.0003506434,0.001530311,0.0007522351,0.0005329878,0.0004872562,0.0004845296,0.001446018,0.000267741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001078277,"about_ca_system_score_gemma":0.001386635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002337572,"about_ca_topic_score_gemma":0.006133916,"domain_scores_codex":[0.9987195,0.000802024,0.00005481362,0.0001846549,0.0001202719,0.0001188324],"domain_scores_gemma":[0.9976681,0.000785878,0.0007231432,0.0001504916,0.000152927,0.0005195062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8650233,0.001401235,0.1063625,0.0007175792,0.003744704,0.0001350106,0.00007495238,0.001156438,0.003903507,0.00008231759,0.00146064,0.01593777],"study_design_scores_gemma":[0.33836,0.1249812,0.5103577,0.0002077627,0.01235172,0.000500583,0.0001387726,0.007976866,0.001752695,0.0002646894,0.002995157,0.000112811],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941686,0.003244984,0.0001693544,0.0002960688,0.00005005094,0.0003736584,0.001058554,0.00001795364,0.0006207576],"genre_scores_gemma":[0.996188,0.0005927553,0.0002730902,0.0001938186,0.0001231583,0.0002952668,0.001876844,0.00000855269,0.0004484797],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003534603,"threshold_uncertainty_score":0.01869297,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07469459667457762,"score_gpt":0.4383141343358714,"score_spread":0.3636195376612937,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}